Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice
Aurora Magliocca(University of Milan), Giuseppe Ristagno(Italian Resuscitation Council), Roberto Latini(Mario Negri Institute for Pharmacological Research), Carlo Perego(American Heart Association), Alessandra Mandelli(American Heart Association), Francesca Fumagalli(Mario Negri Institute for Pharmacological Research), Giulia Merigo(American Heart Association), F. Motta(American Heart Association), Davide Olivari(American Heart Association), Jacopo Lucchetti(American Heart Association), Roberto Furlan(Vita-Salute San Raffaele University), Fumito Ichinose(Harvard University), Markus B. Skrifvars(Helsinki University Hospital), Marco Gobbi(Mario Negri Institute for Pharmacological Research), Edoardo Micotti(Mario Negri Institute for Pharmacological Research), Giacomo Bellani(University of Trento)
Cited by 9
Related Papers
Part 4: Advanced Life Support
|Circulation|2015|1.4k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|737
Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations
|Resuscitation|2020|622
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|586